Obsidian Therapeutics, Inc., a biotechnology company pioneering engineered cell and gene therapies, has appointed Lee Giguere as Chief Legal Officer and Secretary.
Giguere will manage the legal function and serve as a key member of Obsidian’s executive leadership team, playing a critical role in the company’s strategic decision-making. He will provide operational leadership across a wide array of legal, governance and compliance matters.
Giguere has wide-ranging experience and expertise in legal, healthcare compliance and corporate governance for public life science companies. He most recently served as general counsel and secretary at the biotechnology company Chiasma, Inc., responsible for all legal, compliance and human resource matters. Before joining Chiasma, he spent several years with Karyopharm Therapeutics Inc. as deputy general counsel, assistant secretary; and Boston Scientific Corporation as senior securities and governance counsel.
Giguere began his legal career as an associate in the business law practice with Goodwin Procter. Lee earned his J.D. from Northeastern University School of Law and his B.S. from Northeastern University.
Headquartered in Cambridge, Mass., Obsidian Therapeutics is set to take its first cytoTIL15 program (OBX-115) into the clinic this year, expecting to submit an IND for OBX-115 in the middle of the year.